Bacteria deplete deoxynucleotides to defend against bacteriophage infection

Nitzan Tal, Adi Millman, Avigail Stokar Avihail, Taya Fedorenko, Azita Leavitt, Sarah Melamed, Erez Yirmiya, Carmel Avraham, Alexander Brandis, Tevie Mehlman, Gil Amitai, Rotem Sorek

Research output: Contribution to journalArticlepeer-review

Abstract

DNA viruses and retroviruses consume large quantities of deoxynucleotides (dNTPs) when replicating. The human antiviral factor SAMHD1 takes advantage of this vulnerability in the viral lifecycle, and inhibits viral replication by degrading dNTPs into their constituent deoxynucleosides and inorganic phosphate. Here, we report that bacteria use a similar strategy to defend against bacteriophage infection. We identify a family of defensive bacterial deoxycytidine triphosphate (dCTP) deaminase proteins that convert dCTP into deoxyuracil nucleotides in response to phage infection. We also identify a family of phage resistance genes that encode deoxyguanosine triphosphatase (dGTPase) enzymes, which degrade dGTP into phosphate-free deoxyguanosine and are distant homologues of human SAMHD1. Our results suggest that bacterial defensive proteins deplete specific deoxynucleotides (either dCTP or dGTP) from the nucleotide pool during phage infection, thus starving the phage of an essential DNA building block and halting its replication. Our study shows that manipulation of the dNTP pool is a potent antiviral strategy shared by both prokaryotes and eukaryotes.
Original languageEnglish
Pages (from-to)1200-1209
Number of pages10
JournalNature Microbiology
Volume7
Issue number8
Early online date11 Jul 2022
DOIs
StatePublished - Aug 2022

Fingerprint

Dive into the research topics of 'Bacteria deplete deoxynucleotides to defend against bacteriophage infection'. Together they form a unique fingerprint.

Cite this